Publisher
Springer Science and Business Media LLC
Reference107 articles.
1. Xia, H. et al. Hematocrit levels and hospitalization risks in hemodialysis. J. Am. Soc. Nephrol. 10, 1309–1316 (1999).
2. Ma, J. Z. et al. Hematocrit level and associated mortality in hemodialysis patients. J. Am. Soc. Nephrol. 10, 610–619 (1999).
3. Foley, R. N. et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am. J. Kidney Dis. 28, 53–61 (1996).
4. Kliger, A. S. et al. Erythropoietic stimulating agents and quality of a patient's life: individualizing anemia treatment. Clin. J. Am. Soc. Nephrol. 7, 354–357 (2012).
5. Locatelli, F. et al. Anaemia in haemodialysis patients of five European countries: association with morbidity and mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol. Dial. Transplant. 19, 121–132 (2004).
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献